IPH4102, a humanized KIR3DL2 antibody with potent activity against cutaneous T-cell lymphoma.
| Image |  |
|---|---|
| Description | scientific article published in November 2014 |
| Author/s | |
| Publication date | November 1, 2014 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |